BI Salman, RE Saraya, YF Hassan, AI Hassan… - Bioanalysis, 2025 - Taylor & Francis
ABSTRACT Aims Gastrointestinal stromal tumors (GISTs) account for about 80% of the mesenchymal tumors of the GI tract. About 5000–6000 patients are diagnosed in the United …
The development of potent BRAF inhibitors has revolutionized the treatment of BRAF mutant cancers, in particular, melanomas. However, BRAF mutant cancers of other entities, eg …
A Chen, X Zhang - Cancers, 2023 - pmc.ncbi.nlm.nih.gov
We carefully read the article written by Golcic et al.“Evaluation of Systemic Treatment Options for Gastrointestinal Stromal Tumours”[1]. The authors included the dose escalation …
We appreciate the comment made by Chen et al. on our manuscript evaluating the systemic treatment options for gastrointestinal stromal tumours (GIST)[1]. Their comment serves as a …